One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Bioinformatics Services Market

バイオインフォマティクスサービス市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2023年


[ 英語タイトル ] Bioinformatics Services Market by Type (Microbiome, Transcriptome, Virtual Screening, Database Management), Specialty (Medical, Forensics), Application (Proteomics, Metabolomics), End User (Academia, Pharma) - Global Forecast to 2023


Product Code : MNMHC00109688
Survey : MarketsandMarkets
Publish On : May, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global bioinformatics services market projected to grow at a CAGR of 15.7%.”
The global bioinformatics services market is projected to reach USD 3.53 billion by 2023 from USD 1.70 million in 2018, at a CAGR of 15.7%. Factors such as increasing applications of bioinformatics in various industries, the shortage of skilled bioinformatics professionals leading to increased outsourcing of bioinformatics projects, and rising public-private sector funding for bioinformatics services are expected to propel the growth of this market. However, the in-house development of bioinformatics solutions and publically available bioinformatics tools are expected to restrain the growth of the bioinformatics services market in the forecast period.

“The medical biotechnology segment is expected to dominate the market in 2018.”
The bioinformatics services market, by specialty, is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, and forensic biotechnology. The medical biotechnology segment is expected to command the largest share of the bioinformatics services market in 2018. The largest share of this segment can be attributed to the development of new databases for drug discovery, the use of bioinformatics for clinical diagnostics, and increasing funding for the development of bioinformatics solutions for clinical diagnostics.

“The academic institutes and research centers segment to grow at the highest CAGR during 2018 to 2023.”
On the basis of end user, the bioinformatics services market is segmented into academic institutes and research centers, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users. The academic institutes and research centers segment is estimated to witness the highest growth during 2018–2023. Increasing scale of genomics research, rising number of collaborations between academic research institutes and players in the bioinformatics market, growing number of government funding programs for genomics research, and the increasing focus of market players on providing efficient bioinformatics services that suit the requirements of researchers are some of the major factors driving the growth of this segment.

“APAC is projected to witness the highest growth during the forecast period.”
The Asia Pacific bioinformatics services market is expected to grow at the highest CAGR from 2018 to 2023. Factors such as increasing incidence of target diseases (such as cancer and genetic diseases), rising awareness about the clinical applications of bioinformatics and its advantages over conventional methods, and growing genomic and drug discovery research activities are driving the growth of the Asia Pacific bioinformatics services market.

Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type - Tier 1 –26%, Tier 2 –33% and Tier 3 –41%
• By Designation – C-level – 43%, Director-level – 36%, Others – 22%
• By Region – North America – 33%, Europe – 21%, APAC – 37%, RoW – 9%

As of 2017, the key players in the bioinformatics services market include Illumina (US), Thermo Fisher Scientific (US), Eurofins Scientific (Luxembourg), BGI (China), NeoGenomics (US), PerkinElmer (US), CD Genomics (US), Macrogen (South Korea), QIAGEN (Germany), GENEWIZ (US), Source BioScience (UK), Microsynth (Switzerland), MedGenome (India), Fios Genomics (UK), and BaseClear (Netherlands), among others.

Research Coverage
This report studies the bioinformatics services market based on type, specialty, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on business strategies adopted by the major players in the bioinformatics services market. The report analyzes the bioinformatics services market based on type, specialty, application, end user, and region

• Service Launches: Insights on R&D activities and service launches in the bioinformatics services market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various bioinformatics services across geographies

• Market Diversification: Exhaustive information about recent developments and investments in the bioinformatics services market

• Competitive Assessment: In-depth assessment of market ranking, strategies, and services of leading players in the bioinformatics services market

TABLE OF CONTENTS

1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 MARKET SCOPE 13
1.3.1 MARKETS COVERED 13
1.3.2 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 14
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 RESEARCH DATA 16
2.1.1 SECONDARY DATA 17
2.1.1.1 Secondary sources 17
2.1.2 PRIMARY DATA 17
2.1.2.1 Breakdown of primaries 18
2.1.2.2 Primary sources 18
2.2 MARKET SIZE ESTIMATION 19
2.2.1 BOTTOM-UP APPROACH 19
2.2.2 TOP-DOWN APPROACH 20
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.4 ASSUMPTIONS 22
3 EXECUTIVE SUMMARY 23
4 PREMIUM INSIGHTS 27
4.1 BIOINFORMATICS SERVICES: MARKET OVERVIEW 27
4.2 BIOINFORMATICS SERVICES MARKET, BY TYPE (2018 VS. 2023) 28
4.3 BIOINFORMATICS SERVICES MARKET, BY APPLICATION (2018 VS. 2023) 29
4.4 BIOINFORMATICS SERVICES MARKET, BY SPECIALTY (2018 VS. 2023) 29
4.5 BIOINFORMATICS SERVICES MARKET, BY REGION AND END USER,
2018 VS. 2023 (USD MILLION) 30
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.2 MARKET DYNAMICS 31
5.2.1 DRIVERS 32
5.2.1.1 Growing applications of bioinformatics in various industries 32
5.2.1.2 Increasing public-private sector funding for bioinformatics services 32
5.2.1.3 Shortage of skilled bioinformatics professionals leading to increased outsourcing of bioinformatics projects 33
5.2.2 RESTRAINTS 33
5.2.2.1 In-house development of bioinformatics solutions and publically available bioinformatics tools 33
5.2.3 OPPORTUNITIES 34
5.2.3.1 Reducing cost of sequencing and growing volume of data generated during sequencing 34
5.2.3.2 Growing focus on outsourcing for the management of large volumes of data 35
5.2.3.3 Emerging markets 35
5.2.4 CHALLENGES 35
5.2.4.1 Complexity of data 35
5.2.4.2 Lack of well-defined standards for bioinformatics analysis 36
6 BIOINFORMATICS SERVICES MARKET, BY TYPE 37
6.1 INTRODUCTION 38
6.2 SEQUENCING SERVICES 39
6.2.1 WHOLE GENOME SEQUENCING AND DE NOVO ASSEMBLY 41
6.2.2 EXOME ANALYSIS 42
6.2.3 TRANSCRIPTOME ANALYSIS 43
6.2.4 METAGENOMIC ANALYSIS 44
6.2.5 CHIP-SEQ ANALYSIS 44
6.2.6 OTHER SEQUENCING ANALYSIS 45
6.3 DATA ANALYSIS 46
6.3.1 DATA MINING 48
6.3.2 GENOMIC ANALYSIS 49
6.3.3 PROTEOMIC ANALYSIS 50
6.3.4 VARIANT ANNOTATION AND DISCOVERY 51
6.4 DRUG DISCOVERY SERVICES 52
6.5 DIFFERENTIAL GENE EXPRESSION ANALYSIS 53
6.6 DATABASE AND MANAGEMENT SERVICES 55
6.7 OTHER BIOINFORMATICS SERVICES 56
7 BIOINFORMATICS SERVICES MARKET, BY SPECIALTY 58
7.1 INTRODUCTION 59
7.2 MEDICAL BIOTECHNOLOGY 60
7.3 ANIMAL BIOTECHNOLOGY 61
7.4 PLANT BIOTECHNOLOGY 62
7.5 ENVIRONMENTAL BIOTECHNOLOGY 63
7.6 FORENSIC BIOTECHNOLOGY 64

8 BIOINFORMATICS SERVICES MARKET, BY APPLICATION 65
8.1 INTRODUCTION 66
8.2 GENOMICS 67
8.3 CHEMOINFORMATICS & DRUG DESIGN 68
8.4 PROTEOMICS 69
8.5 TRANSCRIPTOMICS 70
8.6 METABOLOMICS 71
8.7 OTHER APPLICATIONS 72
9 BIOINFORMATICS SERVICES MARKET, BY END USER 73
9.1 INTRODUCTION 74
9.2 ACADEMIC INSTITUTES & RESEARCH CENTERS 75
9.3 HOSPITALS & CLINICS 76
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 77
9.5 OTHER END USERS 78
10 BIOINFORMATICS SERVICES MARKET, BY REGION 80
10.1 INTRODUCTION 81
10.2 NORTH AMERICA 83
10.3 EUROPE 87
10.4 ASIA PACIFIC 91
10.5 REST OF THE WORLD 95
11 COMPETITIVE LANDSCAPE 98
11.1 INTRODUCTION 98
11.2 MARKET RANKING ANALYSIS, BY KEY PLAYER, 2017 99
11.3 COMPETITIVE SITUATION AND TRENDS 100
11.3.1 SERVICE LAUNCHES 100
11.3.2 AGREEMENTS, PARTNERSHIPS AND COLLABORATIONS 101
11.3.3 EXPANSIONS 101
11.3.4 ACQUISITIONS 102
12 COMPANY PROFILES 103
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 BASECLEAR 103
12.2 BGI 104
12.3 CD GENOMICS 105
12.4 EUROFINS SCIENTIFIC 106
12.5 FIOS GENOMICS 108
12.6 GENEWIZ 109
12.7 ILLUMINA 110
12.8 MACROGEN 112
12.9 MEDGENOME LABS 115
12.10 MICROSYNTH 117
12.11 NEOGENOMICS 118
12.12 PERKINELMER 120
12.13 QIAGEN BIOINFORMATICS 122
12.14 SOURCE BIOSCIENCE 124
12.15 THERMO FISHER SCIENTIFIC 126

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 129
13.1 DISCUSSION GUIDE 129
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 133
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 135
13.4 AVAILABLE CUSTOMIZATIONS 137
13.5 RELATED REPORTS 137
13.6 AUTHOR DETAILS 138

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+